Achelois BioPharma Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Achelois BioPharma General Information
Description
Developer of programmable multivalent therapeutics designed to target multiple molecules underlying complex diseases. The company's drugs target single molecules, these therapeutics can attack various disease hallmarks simultaneously, enabling patients with precise and potentially curative approaches to treating complex illnesses.
Contact Information
Website
www.achelois.bioCorporate Office
- 3698 Haven Avenue
- Suite A
- Redwood City, CA 94063
- United States
Corporate Office
- 3698 Haven Avenue
- Suite A
- Redwood City, CA 94063
- United States
Achelois BioPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Achelois BioPharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| QB3 | Accelerator/Incubator |
Achelois BioPharma FAQs
-
When was Achelois BioPharma founded?
Achelois BioPharma was founded in 2013.
-
Where is Achelois BioPharma headquartered?
Achelois BioPharma is headquartered in Redwood City, CA.
-
What industry is Achelois BioPharma in?
Achelois BioPharma’s primary industry is Drug Discovery.
-
Is Achelois BioPharma a private or public company?
Achelois BioPharma is a Private company.
-
What is Achelois BioPharma’s current revenue?
The current revenue for Achelois BioPharma is .
-
Who are Achelois BioPharma’s investors?
QB3 has invested in Achelois BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process